You are here

  • Home
  • Archive
  • Volume 76, Issue 6
  • Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Braun J, Baraliakos X, Deodhar A for the MEASURE 1 study group, et al
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
Annals of the Rheumatic Diseases 2017;76:1070-1077.